Helsinn

Investments

6

Lead Investments

2

Helsinn is a fully integrated biopharma company with a strong focus on oncology and rare diseases. With over forty years of commercial execution, Helsinn is a leader in supportive care, aiming to improve the health and quality of life of patients with cancer and chronic conditions.

Founded 1976

Europe, Switzerland

501-1K

helsinn.com